Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shexiang Zhuanggu Gao is a traditional Chinese medicine (TCM) topical analgesic plaster manufactured by Guangdong Zhanjiang Jimin Pharmaceutical. It is an over-the-counter (OTC) medication widely used in China for the relief of musculoskeletal pain. The formulation typically includes a combination of synthetic active ingredients such as menthol, camphor, and methyl salicylate, alongside traditional components like artificial musk (artificial shexiang) and various herbal extracts (e.g., Radix Aconiti, Rhizoma Atractylodis). These ingredients work synergistically to provide local analgesic and anti-inflammatory effects, promote blood circulation, and dispel 'wind-dampness' according to traditional indications. It is primarily indicated for conditions such as rheumatism, joint pain, lower back pain, neuralgia, muscle aches, and sprains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shexiang Zhuanggu Gao.